All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @findandthrive on TikTok · 107s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @findandthrive's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00One full year of taking BPC-157 to relieve joint and gut pain.
  2. 0:03This is why I am stopping.
  3. 0:05Even being relatively young, I've been going to the gym for a few years.
  4. 0:07A lot of days, it was really hard to wake up and actually get myself to the gym.
  5. 0:11I was not recovering well at night.
  6. 0:13It was resulting in a lot of injury.
  7. 0:14My joints felt like freaking glass, which shouldn't be the case for someone my dad has been taking BPC-157 for a long time.
  8. 0:21And he's 70 some years old and he's in great shape.
  9. 0:24And I was like, am I too young to start that?
  10. 0:26My dad hasn't had any pain at all in his joints or any arthritis since he started taking it.
  11. 0:30And so I figured it might as well give it a shot to see if it works for me.
  12. 0:32I originally started taking the shots, but I could not keep up with the price.
  13. 0:36That's the nice that I'm going to give the capsules a freaking shot.
  14. 0:38Why not?
  15. 0:39Week one of taking the capsules, no major difference.
  16. 0:41Week two and week three is when I really started to feel it.
  17. 0:44I started waking up with a lot less joint pain.
  18. 0:47Not only that, my gains in the gym have went insane.
  19. 0:51I don't really take a whole lot of supplements, just protein powder really.
  20. 0:55I'm recovering better now than ever before.
  21. 0:57And I haven't made any significant changes to my lift or my sleep schedule or my diet.
  22. 1:00I just started taking BPC capsules every single day, two times a day.
  23. 1:03It took a little bit longer to kick in than the shots, but the recovery has been insane.
  24. 1:07I have full mobility in both my shoulders, which was been a big issue for me.
  25. 1:11And the biggest surprise of everything was my gut.
  26. 1:13I have not had a single gut problem in the last six months that started taking the capsules.
  27. 1:17Like my stomach feels great.
  28. 1:18In a lot of days, there are days when my joints maybe felt okay, but my stomach didn't feel good.
  29. 1:22I don't have that problem anymore.
  30. 1:23Which is, I think the perk of taking the capsules over the shots right now, it saves me money
  31. 1:27and actually heals my gut.
  32. 1:28The only reason I'm considering stopping is that I just don't want to be reliant on this
  33. 1:31stuff.
  34. 1:32I mean, it really, really works, but I do want my body to heal naturally.
  35. 1:35So between recovering, like I did years ago and my gut feeling like it does, I'd highly
  36. 1:39recommend trying the capsules.
  37. 1:40If you haven't already, these are the ones from Unclabs.
  38. 1:42They are lab tested.
  39. 1:44If you want to check the reviews out, I will leave a link right down here in the bottom
  40. 1:46left.

@findandthrive's peptide therapy claims need more evidence

Find and Thrive

TikTok creator

13.5K viewsWatch on TikTok

Quick answer

The creator used oral BPC-157 capsules twice daily for approximately six months after discontinuing injectable BPC-157 due to cost, reporting improvements in shoulder mobility, joint pain, gym recovery, and gastrointestinal symptoms. BPC-157 has no completed human clinical trials in any form, and oral capsule bioavailability for systemic effects remains unestablished in peer-reviewed literature. The FDA removed BPC-157 from eligible compounding substances in 2023, making its current regulatory status for consumer sale in capsule form legally ambiguous.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @findandthrive's peptide therapy claims need more evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@findandthrive's peptide therapy claims need more evidence is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@findandthrive's peptide therapy claims need more evidence" from Find and Thrive. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator used oral BPC-157 capsules twice daily for approximately six months after discontinuing injectable BPC-157 due to cost, reporting improvements in shoulder mobility, joint pain, gym recovery, and gastrointestinal symptoms.

The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7537749956220783886." In this clip, the useful excerpt is: "One full year of taking BPC-157 to relieve joint and gut pain." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Oral bioavailability for systemic peptide effects is biologically questionable.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator used oral BPC-157 capsules twice daily for approximately six months after discontinuing injectable BPC-157 due to cost, reporting improvements in shoulder mobility, joint pain, gym recovery, and gastrointestinal symptoms.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator used oral BPC-157 capsules twice daily for approximately six months after discontinuing injectable BPC-157 due to cost, reporting improvements in shoulder mobility, joint pain, gym recovery, and gastrointestinal symptoms. BPC-157 has no completed human clinical trials in any form, and oral capsule bioavailability for systemic effects remains unestablished in peer-reviewed literature. The FDA removed BPC-157 from eligible compounding substances in 2023, making its current regulatory status for consumer sale in capsule form legally ambiguous.
  • BPC-157 has no completed human clinical trials in any form. All mechanistic data comes from rodent and in vitro studies.
  • Oral bioavailability for systemic peptide effects is biologically questionable. Peptides are degraded by stomach acid and enzymes, which is why injectable forms have been the standard in research.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • BPC-157 has no completed human clinical trials in any form. All mechanistic data comes from rodent and in vitro studies.
  • Oral bioavailability for systemic peptide effects is biologically questionable. Peptides are degraded by stomach acid and enzymes, which is why injectable forms have been the standard in research.
  • Local gut protective effects are the most plausible mechanism for oral BPC-157 capsules, supported by animal GI studies (Chang et al., 2011, Journal of Physiology-Paris), though human data is absent.
  • The FDA removed BPC-157 from the list of bulk substances eligible for pharmacy compounding in 2023, changing its legal landscape for clinical use in the United States.
  • Attributing muscle performance gains to BPC-157 is not supported by any published research. The compound has no known anabolic mechanism.
  • Consumer peptide products labeled 'lab tested' carry no standardized regulatory verification. Buyers should request third-party certificates of analysis before purchasing.
  • Chronic joint pain and recurring GI symptoms warrant clinical evaluation. An unregulated peptide purchased through a social media link is not a substitute for diagnosis and evidence-based treatment.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @findandthrive actually say?

The creator spent a year taking BPC-157, first as injectable peptide, then switching to oral capsules from a company called Unclabs. They credit the capsules with fixing joint pain, improving gym recovery, and eliminating gut problems. They say they want to stop because they "don't want to be reliant on this stuff" and want their body to heal naturally. They also reference their 70-year-old father using BPC-157 long-term with zero joint pain as the original motivation.

This is a product recommendation video. The creator leaves a purchase link, names a specific brand, and describes the capsules as "lab tested." Whether or not they were paid to post this, it functions as an advertisement. That context matters when evaluating how the experience is described.

Does the science back this up?

The honest answer is: partially, but mostly in animals. BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. Preclinical data is genuinely interesting. The human evidence is nearly nonexistent.

Rat and rodent studies have shown BPC-157 accelerates tendon-to-bone healing, reduces inflammation in colitis models, and appears to modulate dopamine and serotonin pathways (Sikiric et al., 2018, Current Pharmaceutical Design). For gut healing specifically, the animal data on inflammatory bowel models is consistent enough that researchers have taken it seriously. Chang et al. (2011, Journal of Physiology-Paris) documented significant mucosal healing in rodent ulcer models using injected BPC-157.

The problem is the route of administration. Oral BPC-157 in capsule form faces a serious bioavailability question. Peptides are broken down by stomach acid and digestive enzymes. The creator switching from injections to capsules and reporting better results is biologically counterintuitive. There are no published human clinical trials for oral BPC-157 capsules at all.

What did they get wrong (or right)?

They got the gut mechanism directionally right by accident. BPC-157 does show gastrointestinal protective effects in animal research, and local action in the gut from an oral dose is actually the most scientifically defensible use case for capsules. If the peptide is acting locally on gut mucosa before being degraded, that is at least a plausible mechanism. Credit where it is due.

What they got wrong is significant. Attributing muscle gains to BPC-157 is not supported by any research. The creator says their gym gains "went insane" and they are recovering better than ever, while having made no changes to training, sleep, or diet. That is a red flag for attribution error. BPC-157 is not a growth hormone secretagogue. It does not directly stimulate muscle protein synthesis. Confusing recovery support with anabolic effect is a real problem in how this compound gets marketed online.

The claim that their father has had "no pain at all" and "no arthritis" from BPC-157 is anecdotal and impossible to verify. Arthritis does not reverse. If the father has less pain, that is worth noting, but it is not the same as the condition being treated or resolved.

What should you actually know?

BPC-157 is not FDA approved for any human use. It is not a regulated drug, not a supplement under DSHFA definitions, and its legal status for sale as a capsule is genuinely murky in the United States. The FDA issued guidance in 2023 removing BPC-157 from the list of substances eligible for compounding, meaning licensed compounding pharmacies can no longer legally produce it for patient use.

Buying peptide capsules from a direct-to-consumer brand is a different regulatory category than a compounding pharmacy, and the risks differ accordingly. "Lab tested" on a product label tells you nothing specific about what was tested, what the acceptable limits were, or who conducted the testing. Third-party certificate of analysis documents are worth asking for before purchasing anything in this category.

If you are dealing with chronic joint pain or gut issues, those symptoms warrant an actual clinical evaluation. There are evidence-based options for both. Using an unregulated peptide without a provider's oversight because a TikTok video connected with you is not a substitute for that.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Find and Thrive · TikTok creator

13.5K views on this video

@findandthrive's peptide therapy claims need more evidence

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about bpc-157 has no completed human clinical trials in any form.?

BPC-157 has no completed human clinical trials in any form. All mechanistic data comes from rodent and in vitro studies.

What does the video say about oral bioavailability for systemic peptide effects?

Oral bioavailability for systemic peptide effects is biologically questionable. Peptides are degraded by stomach acid and enzymes, which is why injectable forms have been the standard in research.

What does the video say about local gut protective effects?

Local gut protective effects are the most plausible mechanism for oral BPC-157 capsules, supported by animal GI studies (Chang et al., 2011, Journal of Physiology-Paris), though human data is absent.

What does the video say about the fda removed bpc-157 from the list of bulk substances?

The FDA removed BPC-157 from the list of bulk substances eligible for pharmacy compounding in 2023, changing its legal landscape for clinical use in the United States.

What does the video say about attributing muscle performance gains to bpc-157?

Attributing muscle performance gains to BPC-157 is not supported by any published research. The compound has no known anabolic mechanism.

What does the video say about consumer peptide products labeled 'lab tested' carry no standardized regulatory?

Consumer peptide products labeled 'lab tested' carry no standardized regulatory verification. Buyers should request third-party certificates of analysis before purchasing.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Find and Thrive, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.